InsidersTradesSigma
Track the 欧林生物 share price and the full directors' dealings record of the company, a listed issuer based in China. Shares are quoted on the CN market, under the authority of SSE / SZSE (CSRC). Operating in the Health Care sector, 欧林生物 has logged 11 insider filings. Market capitalisation: €10.5bn. The latest transaction was disclosed on 27 July 2026 (Purchase). Among the most active insiders: 陈克平. Every trade is free.
11
Insider Decl.
n/a
Thresholds
€50,307
2 ops.
Buy Volume
€456,860
9 ops.
Sell Volume
12Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 19,411 of 29,053 companies
40.8
score / 100
Value36
Quality45
FCF yld0.1%
Earn yld0.2%
EV/EBITDA·
ROE-2.7%
Gross mgn93%
Net mgn3.2%
Debt/EBITDA5.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 27 July 2026
Declarations11 total
11 of 11 declarations
About 欧林生物
欧林生物 is a company specializing in the healthcare and pharmaceutical sector. It is listed on the XSHG market.